What is Comanche Biopharma worth?
$210.0Mlast known valuation
Comanche Biopharma last raised $37.5M in its Early Stage VC (Dec 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Comanche Biopharma
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2023 | Early Stage VC | $37.5M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $36.1M | ▮ | ▮ |
How Comanche Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Comanche Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Comanche Biopharma worth?
- Comanche Biopharma's last known valuation is $210.0M.
- How much has Comanche Biopharma raised?
- Comanche Biopharma has raised $136.1M in total funding across 2 recorded rounds.
- When did Comanche Biopharma last raise?
- Comanche Biopharma last raised in Dec 2023 (Early Stage VC), raising $37.5M.